Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP science news

Show

From To
No new infections during research on preventive HIV pill in Belgium

According to the latest figures from Sciensano, 890 new diagnoses were made in Belgium last year, mainly in gay men and people from sub-Saharan Africa. This is a decrease of 27% compared to the peak of 2012.

Published
27 November 2018
From
Institute of Tropical Medicine
HIV Seroconversion Despite PrEP Therapy

The tragedy of continued HIV transmission in the era of pre-exposure prophylaxis (PrEP) is explored in detail in a viewpoint article published in Clinical Infectious Diseases.1 The study evaluated a cohort of 14 young black men who have sex with men (MSM) in Atlanta, Georgia, who experienced HIV seroconversion despite administration of PrEP as part of the EleMENt Study.

Published
22 November 2018
From
Infectious Disease Advisor
Removable PrEP implant produces high drug levels in rabbits; further studies planned

A small removable plastic implant resembling a tiny piece of dry spaghetti is capable of delivering sustained levels of the drug tenofovir, researchers told last month’s HIV

Published
15 November 2018
By
Gus Cairns
PROUD qualitative findings: PrEP’s impact on sexual behaviour

Qualitative data from the PROUD study revealed that pre-exposure prophylaxis (PrEP) is an important added prevention tool to strategies already in place for men in England having

Published
13 November 2018
By
Krishen Samuel
Trying to prevent and diagnose HIV at the same time – a Catch-22?

The doctors were puzzled by the fact that it wasn’t quite HIV. If it became HIV they could treat it. If it didn’t become HIV and went away they could discharge him. But this just being short of HIV all the time confused them.

Published
11 November 2018
From
Daily Maverick
Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure

Published
09 November 2018
By
Gus Cairns
How to evaluate PrEP and vaccines: urgency for next generation compounds

Several presentations at R4P 2018 looked at the new challenges of evaluating efficacy of new PrEP and vaccine candidates.

Published
05 November 2018
From
HIV i-Base
PrEP Is Safe for Pregnant Women Who Want the HIV Prevention Drug, a New Study Finds

Pre-exposure prophylaxis, or PrEP, is safe for pregnant women to use, according to new research presented at the HIV Research for Prevention (HIVR4P2018) conference in Madrid, Spain.

Published
05 November 2018
From
The Body Pro
How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

A meta-analysis of randomised controlled trials of tenofovir or tenofovir/emtricitabine as pre-exposure prophylaxis (PrEP) has found no increase in the risk of serious adverse health

Published
02 November 2018
By
Gus Cairns
Going local – prevention conference hears about rings, douches, and soluble suppositories

Last week’s HIV Research for Prevention conference (HIVR4P 2018) in Madrid heard a lot about oral pre-exposure prophylaxis (PrEP): not only its efficacy but also

Published
31 October 2018
By
Gus Cairns
← First12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.